Assessment of Gliflozins prescribing pattern in a United Arab Emirates tertiary-level care hospital
Gliflozin prescribing patterns in the UAE reflect global trends, with increased use among patients with diabetes, HF, and CKD. Further research is recommended to explore factors influencing prescription practices and optimize Gliflozin therapy if gliflozins use considerably increase in new diagnosis of diabetes and CKD even in mild conditions.
Authors
- Seeba Zachariah (ORCID: https://orcid.org/0000-0003-2568-0244)
- Wessa Shenouda (ORCID: https://orcid.org/0000-0002-5979-6408)
- Dixon Thomas
- Omar Nabi
Institutions
- Gulf Medical University (AE)
- Thumbay Group (United Arab Emirates) (AE)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.3389/fphar.2025.1529528
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00